ARYx Therapeutics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ARYx Therapeutics Inc. - overview
Established
1997
Location
Fremont, CA, US
Primary Industry
Biotechnology
About
ARYx Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutic solutions aimed at improving patient outcomes in various medical conditions. Founded in 1997 and headquartered in Fremont, US, ARYx Therapeutics Inc. specializes in biotechnology.
It has undergone significant changes in its business strategy over time. The company has engaged in 8 investment deals and recently raised USD 6. 3 mn in a VENTURE DEBT round from Lighthouse Capital Partners, contributing to a total of USD 0. 35 mn raised.
The founder's information is not specified. ARYx Therapeutics Inc. is dedicated to developing therapeutic solutions that address unmet medical needs. Its portfolio includes advanced drug formulations targeting specific health issues, with a focus on enhancing patient treatment efficacy.
The company primarily serves the healthcare sector, catering to diverse medical applications and patient demographics. The company's revenue for the most recent year, 2009, was reported at USD 0. 00, with an EBITDA reflecting a loss of USD 29,751,000. This indicates challenges in maintaining revenue streams during that period.
ARYx Therapeutics Inc. has ceased operations, and as such, no future growth plans or new product launches are currently being pursued. The company's last funding round was designated to support ongoing operations, but no further information is available regarding future initiatives.
Current Investors
OrbiMed Advisors, MPM BioImpact, Merlin.dk
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.aryx.com
Company Stage
Ceased Operations
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.